Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Cuprina Holdings (Cayman) Limited Class A ( (CUPR) ) just unveiled an update.
On November 26, 2025, Cuprina Holdings received a notice from Nasdaq indicating that its Class A ordinary shares had fallen below the $1.00 minimum bid price requirement for 30 consecutive business days. The company has been given a 180-day compliance period, until May 26, 2026, to rectify this issue. If compliance is not regained, Cuprina may qualify for an additional 180-day grace period by meeting other listing standards and potentially executing a reverse stock split. The notification does not immediately affect the trading of Cuprina’s shares, which will continue under the symbol ‘CUPR.’ Cuprina is actively exploring options to regain compliance, though there is no assurance of success.
More about Cuprina Holdings (Cayman) Limited Class A
Cuprina Holdings (Cayman) Limited is a Singapore-based biomedical and biotechnology company focused on developing and commercializing innovative products for chronic wound management and the health and beauty sectors. The company leverages biomedical research to create medical devices from natural materials that meet international standards.
Average Trading Volume: 1,472,019
Technical Sentiment Signal: Strong Sell
Current Market Cap: $4.8M
For an in-depth examination of CUPR stock, go to TipRanks’ Overview page.